Evolution of the Average Target: Newmont Corporation

Evolution of the Target Price: Newmont Corporation

Changes in Analyst Recommendations: Newmont Corporation

b9b8646df753.CykA7NBdJsMa68j-0lS_vY1Xe2n8ftU10n8O1zyR8Ww.Xn11h6QRXoxOp6qwqCDu4rQmTTyWD4V_oxM-o0bAizhjeGWziBRkjFesgQ~5117eec1e84e16d4e471c4c8a9095ba4
01-23 Canaccord Genuity Adjusts Newmont Price Target to $140 From $115, Maintains Buy Rating MT
01-22 TD Cowen Adjusts Newmont Price Target to $120 From $89, Maintains Hold Rating MT
01-20 Jefferies Adjusts Price Target on Newmont to $136 From $120, Maintains Buy Rating MT
01-15 Raymond James Adjusts Price Target on Newmont to $130 From $111, Maintains Outperform Rating MT
01-13 Citigroup Adjusts Price Target on Newmont to $118 From $104, Maintains Buy Rating MT
01-12 Goldman Sachs Adjusts Price Target on Newmont to $123.90 From $99.90, Maintains Buy Rating MT
12-30 Newmont shares rise 2.1% premarket; Raymond James raises target price RE
12-29 Raymond James Adjusts Price Target on Newmont to $111 From $99, Maintains Outperform Rating MT
12-16 BMO Capital Adjusts Newmont Price Target to $114 From $99, Maintains Outperform Rating MT
12-10 RBC Adjusts Price Target on Newmont to $120 From $97, Maintains Outperform Rating MT
12-10 Analyst recommendations: Abbvie, Biogen, PepsiCo, Eli Lilly, Netflix… Zonebourse
12-09 National Bank Adjusts Price Target on Newmont to $120 From $110, Maintains Outperform Rating MT
12-08 Jefferies Adjusts Price Target on Newmont to $120 From $113, Maintains Buy Rating MT
12-05 Analyst recommendations: Humana, Newmont, Robert Half, Apple, Macy's… Zonebourse
12-05 Macquarie Upgrades Newmont to Outperform From Neutral, Adjusts Price Target to $115 From $100 MT
12-05 BNP Paribas Exane Downgrades Newmont to Neutral From Outperform, Adjusts PT to $97 From $107 MT
12-01 UBS Adjusts Newmont Price Target to $125 From $105.50, Maintains Buy Rating MT
11-21 Argus Research Adjusts Newmont Price Target to $94 From $75 MT
11-10 North American Morning Briefing : Stock Futures Boosted by Shutdown Hopes -2- DJ
11-05 BNP Paribas Exane Adjusts Price Target on Newmont to $107 From $92, Maintains Outperform Rating MT
11-04 Bernstein Adjusts Price Target on Newmont to $94 From $96, Maintains Market Perform Rating MT
27/10/25 RBC Raises Barrick's Price Target to US$40 Amid Reported M&A Interest from Newmont MT
27/10/25 Barrick Brief: Keeps Outperform, Target Raised To US$40 From $38 at RBC In "Analysis of a Shotgun Wedding In Nevada" As RBC Notes Unconfirmed Reports of M&A Deal With Newmont MT
26/10/25 Newmont Beats Earnings, Cash Flow Estimates With 'Strong' Third Quarter, Says Jefferies MT
24/10/25 Raymond Jame Adjusts Newmont Price Target to $99 From $96, Maintains Outperform Rating MT
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-4.56%
-2.33%
-3.65%
-1.83%
-4.68%
-15.06%
+4.45%
-3.32%
- -11.86%
+12.85%
Average -3.00%
Weighted average by Cap. -3.77%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
124.31USD
Average target price
119.90USD
Spread / Average Target
-3.55%
High Price Target
160.00USD
Spread / Highest target
+28.71%
Low Price Target
70.00USD
Spread / Lowest Target
-43.69%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Canaccord Genuity
TD Cowen
Jefferies & Co.
Raymond James
Citigroup
Goldman Sachs
BMO Capital
RBC Capital Markets
National Bank
Macquarie
BNP Paribas Exane
UBS
Argus
Bernstein
Scotiabank
National Bank Financial
CIBC World Markets
Stifel Canada
TD Securities
Veritas
Barclays
Vertical Research
Credit Suisse
Exane BNP Paribas
KeyBanc Capital Markets
J.P. Morgan Chase
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
124.31USD
Average target price
119.90USD
Spread / Average Target
-3.55%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NEM Stock
  4. Consensus Newmont Corporation